News Wings

Tag: access

  • Spotlight- Ikechukwu Ofuani: A Master of Government Relations, Public Policy & Public-Private Partnerships

    Spotlight- Ikechukwu Ofuani: A Master of Government Relations, Public Policy & Public-Private Partnerships

    Ikechukwu Sylvester Ofuani, LLB, BL, MPA, DPO (Ghana), is a distinguished lawyer, government affairs strategist, and public policy leader whose career spans more than 18 years across Africa, the United Kingdom, and Ireland. Renowned for his expertise in government relations, regulatory affairs, stakeholder engagement, and policy advocacy, he has built a reputation as one of the leading voices shaping the intersection of public policy, corporate strategy, and development across Sub-Saharan Africa.

    With professional experience cutting across healthcare, MedTech, FMCG, international trade, development, corporate communications, and public-private partnerships, Ikechukwu has consistently demonstrated the ability to navigate complex regulatory environments while fostering strategic collaboration between governments, private institutions, multilateral organisations, and civil society stakeholders.

    Over the years, he has held senior leadership roles at organisations including Policy Vault Africa, Johnson & Johnson, Procter & Gamble, and the National Identity Management Commission project. In these capacities, he has led high-level engagements with governments, regulators, trade associations, development institutions, and international stakeholders, helping organisations shape policy ecosystems, strengthen institutional relationships, and drive sustainable impact.

    A significant part of his professional journey was spent at Johnson & Johnson, where he served as Director of Government Affairs and Policy for West and Central Africa. In that role, he led health system strengthening strategies and coordinated complex partnerships involving governments, donor agencies, regulatory institutions, and healthcare stakeholders across the region. His work focused on policy reform, regulatory harmonisation, strategic communications, grants management, and advocacy initiatives designed to strengthen healthcare delivery systems.

    Ikechukwu also played a strategic role in regional health diplomacy and pandemic preparedness. As one of Johnson & Johnson’s focal persons for African Union engagements on Ebola vaccines and pandemic preparedness, he coordinated engagements involving access teams, regulatory experts, medical affairs specialists, and global public health stakeholders. During the COVID-19 pandemic, he supported vaccine deployment efforts in Nigeria, Ghana, and Cameroon, and contributed to initiatives to address vaccine hesitancy and improve uptake across African countries.

    His contributions to Africa’s healthcare policy ecosystem have attracted continental recognition. He has publicly represented Johnson & Johnson as Director of Worldwide Government Affairs and Policy for West and Central Africa and has participated in high-level conversations on strengthening health regulatory systems, including at the U.S.-Africa Business Summit.

    Beyond multinational corporate leadership, Ikechukwu has also distinguished himself in the advisory and policy consulting space. He currently co-leads PV Advisors and Policy Vault Africa, a policy and government affairs advisory platform that supports organisations navigating Africa’s complex regulatory and stakeholder landscape. Through the platform, he provides strategic guidance to clients across sectors, helping them engage effectively with governments, regulators, policymakers, and development institutions.

    Under his leadership, Policy Vault Africa has contributed to broader governance and institutional reform conversations across the continent. One notable example is the organisation’s engagement with Nigeria’s Ministry of Budget and National Planning on policy digitisation and the preservation of institutional memory. The initiative seeks to improve transparency, accessibility, and the preservation of authentic policy documents for governments, researchers, private-sector actors, and citizens. Ikechukwu has consistently advocated the importance of accessible and credible policy information as a foundation for informed decision-making and long-term development planning.

    Another defining area of his impact has been public health advocacy and child survival initiatives. Ikechukwu currently serves as Project Lead of the SARMAAN Advocacy Team, where he is helping reposition SARMAAN II from a donor-supported intervention into a nationally owned and sustainably financed public health priority. Through strategic advocacy, communications, stakeholder engagement, and sustainability planning, he is supporting efforts to integrate child survival interventions into Nigeria’s broader healthcare policy architecture. His work places strong emphasis on domestic financing, institutional ownership, and building trust among governments, implementing partners, and local communities.

    His ability to transform policy conversations into measurable outcomes is further evident in his work on health system-strengthening partnerships. While at Johnson & Johnson, he successfully secured a ₦300 million healthcare partnership with Kebbi State focused on improving healthcare infrastructure across oncology, mental health, and immunology. The initiative reportedly led to the identification and treatment of over 200 indigent patients and became a model replicated in additional states.

    Prior to his healthcare and advisory engagements, Ikechukwu also recorded significant achievements in trade facilitation and investment enablement during his time at Procter & Gamble Nigeria. There, he led strategic engagements with regulatory agencies and government institutions across West Africa, facilitating multimillion-dollar investment approvals, securing customs fast-track arrangements, and supporting major industrial projects. Among his notable contributions was the coordination of government-facing engagements surrounding the commissioning of a US$300 million diaper manufacturing plant in Agbara, Ogun State, attended by senior government officials including the Vice President of Nigeria.

    Beyond his corporate and policy engagements, Ikechukwu is also committed to social impact and advocacy. He currently sits on the board of Stockport Advocacy in the United Kingdom, an organisation focused on advocating for children with learning disabilities. His leadership and contributions to public-private partnerships and Africa-focused policy engagement have earned him recognition, including being named a 2024 GCC Powerlist awardee.

    What distinguishes Ikechukwu Sylvester Ofuani is his rare combination of legal training, policy expertise, stakeholder intelligence, and strategic leadership. Across multinational corporations, advisory platforms, donor-supported programmes, and government-facing initiatives, he has built a career centred on helping institutions navigate complexity, build trust with governments, and translate policy engagement into tangible social and commercial impact.

    His journey reflects the growing importance of strategic government relations and policy leadership in shaping Africa’s development trajectory. Through his work, Ikechukwu continues to demonstrate that effective engagement between the public and private sectors remains one of the most powerful tools for driving sustainable growth, institutional reform, and transformational impact across the continent.

  • The Rockefeller Foundation injects USD 55 million to get COVID-19 shots

    The Rockefeller Foundation injects USD 55 million to get COVID-19 shots

     The Rockefeller Foundation announced the launch of the Global Vaccination Initiative, a USD 55 million investment over two years to support country-led efforts to fully vaccinate 90% of the most at-risk populations in Africa, Asia, Latin America, and the Caribbean. With this new initiative, the Foundation is focusing its global health resources on supporting locally-driven interventions to increase vaccine demand – access, trust, and information – that have been consistently underestimated, misunderstood, and underfunded in the global COVID-19 response to date, while leveraging data from trusted, credible sources to strengthen health systems and ensure they are meeting the needs of the most vulnerable populations.

    Covid-19 vaccines still represent the world’s best chance at sustainably managing and overcoming the pandemic, yet two years into the pandemic, vaccination rates remain severely inequitable: only 15% of people in low-income countries have received at least one dose, while high-income countries deploy third or even fourth booster shots.

    “The world has every tool it needs to make Covid-19 endemic for everyone, everywhere — but only if those tools are in the hands of the people who need them most,” said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. “With this new commitment, The Rockefeller Foundation will help countries across the Global South reach at-risk populations, simultaneously increasing COVID-19 vaccination rates and building health systems capable of addressing future COVID-19 outbreaks and other public health threats.”

    While global supplies of vaccines increase and stabilize, challenging demand-side issues are preventing countries from accelerating vaccination campaigns. The Access to COVID-19 Tools Accelerator estimates that an additional USD 6.8 billion is needed to support Covid-19 demand generation and expects funding to come directly from countries themselves along with development banks and other international grant financings. This is occurring at a time when the World Bank estimates that low-income nations need 24-30% of their GDP to respond to and recover from the pandemic’s health and economic crises, but with interest rates rising, their external debt outstanding has grown to more than two-thirds of GDP.

    In response, The Rockefeller Foundation’s Global Vaccination Initiative will invest in projects to generate vaccine demand by focusing on three levers:  

    1.   Data and digital tools: Through a demonstrate-and-scale model, investments will support data-driven solutions – applying the latest socio-behavioral insights, digital tools, and data analytics – to provide decision-makers with actionable insights relevant to their contexts and communities to inform the most effective approaches to increase vaccination for most vulnerable groups like at-risk, older adults and frontline health workers.

    2.   Capacity building: To ensure that these data insights are effectively incorporated into vaccination strategies, the Foundation is working with partners on the ground to increase community engagement and mobilization, and build tailored, durable solutions that will prepare health systems for wide-ranging health campaigns for COVID-19 and beyond.  

    3.   Financing: To sustainably support these activities and achieve long-term change, the Foundation will advocate for increased financing to address vaccination demand challenges and additional flexibility in the use of funding to strengthen local health system capabilities for routine immunization and other essential health services.

    “As Covid-19 vaccines are now increasingly available to lower- and middle-income countries, the Global Vaccination Initiative is laser-focused on closing the gap in vaccination rates that exists between richer and poorer countries by addressing the root cause: demand,” said Dr. Bruce Gellin, The Rockefeller Foundation’s Chief of Global Public Health Strategy. “Our approach centers on working together with countries to understand the drivers of demand and barriers to vaccination – only then can we design innovative solutions to swiftly get doses to the most vulnerable communities.”

    Impact Underway

    The Rockefeller Foundation’s Global Vaccination Initiative has already engaged several organizations to implement its strategy, including:

    • United Nations, in collaboration with Purpose, to support Verified, a network of trusted messengers, citizen volunteers and trained media to spread accurate, lifesaving information about COVID-19 vaccinations with the goal of saving lives and countering mis- and disinformation in Africa, Asia, and Latin America. Notably, Brazil’s #AllForVaccines movement became a Twitter trending topic with over 50,000 interactions, South Africa’s Zwakala campaign was officially adopted by South Africa’s national government, and India’s hyper-local campaigns activated 150 community leaders, 10,000 vaccinated auto rickshaw drivers and street vendors, and primary health care workers to disseminate urgent messaging across 33 informal settlements in Delhi.

    ·         COVID Global Accountability Platform (COVID GAP), a partnership between Duke University and COVID Collaborative, to provide evidence-based tracking, insights, and recommendations that collectively help hold the world accountable to meet pressing needs, deliver on commitments, and accelerate the end of the pandemic. COVID GAP released a landmark report in March 2022 calling for an urgent shift in the world’s response to the pandemic from emergency crisis management to a sustainable control strategy that supports country-driven goals that reflect local realities and priorities. This includes prioritizing fully vaccinating (including boosters) high-risk populations with the aim of reaching 90% vaccination coverage.

    ·         Social Science Research Council (SSRC), to launch The Mercury Project, a global consortium of researchers dedicated to identifying evidence-informed tools, methods, and interventions that drive behavior change and combat vaccine mis- and dis-information. Responding to calls from the World Health Organization, the U.S. Office of the Surgeon General, and the Aspen Institute’s Commission on Information Disorder, the consortium will be an essential resource for social media and technology companies and for global policymakers as they build an information ecosystem that supports the sharing of accurate and effective health information for both emergency and routine public health. Research team selection is being finalized and grant awards will be announced this summer.

    ·         Africa Infodemic Response Alliance (AIRA), a platform co-hosted by the WHO Regional Office for Africa, to support the development and testing of new data-driven tools and systems to help field teams in the African region anticipate and respond to waves of health disinformation in real-time.

    ·         AVAC, in partnership with Internews, to grow its existing Media Science Café program in Kenya, Uganda, Zambia and Zimbabwe, to bring journalists together with researchers, implementers, civil society, regulators and policy makers to build relationships that will foster accurate reporting on Covid-19 in those countries. Partners include: Media for Environment Science, Health & Agriculture (MEHSA) in Kenya, Health Journalist Network in Uganda (HEJNU), Media Science Cafe (MESICA) in Zambia and Health Communicators Forum Zimbabwe through a partnership with the Humanitarian Information Facilitation Centre.

    ·         Pulitzer Center to expose the interconnected nature of the systemic inequities made plain by the COVID-19 pandemic – from access to and acceptance of vaccinations to related health-system inequities – bringing these stories to diverse audiences through trustworthy journalism and innovative public engagements.

    The Global Vaccination Initiative, which is part of the Foundation’s historic USD 1 billion commitment to an inclusive, green recovery from the COVID-19 pandemic, is informed by lessons learned from Precision Public Health, an initiative the Foundation launched in 2019 to modernize public health and provide more equitable public health outcomes, and the Equity-First Vaccination Initiative, which supported hyper-local, community-led vaccination strategies to reach 2 million people of color in 5 U.S. cities. It also builds on the Foundation’s century-long legacy in global public health. Investments established the first schools of public health and the global campaign against hookworm; seeded the development of the yellow fever vaccine; supported translational research for tools including penicillin; and spurred AIDS vaccine development. Learn more about the Global Vaccination Initiative and its current grantees here.